Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 20
Filtrar
Más filtros

Bases de datos
Tipo del documento
Intervalo de año de publicación
1.
Plant Cell Physiol ; 65(2): 185-198, 2024 Feb 15.
Artículo en Inglés | MEDLINE | ID: mdl-38153756

RESUMEN

Glycyrrhizin, a type of the triterpenoid saponin, is a major active ingredient contained in the roots of the medicinal plant licorice (Glycyrrhiza uralensis, G. glabra and G. inflata), and is used worldwide in diverse applications, such as herbal medicines and sweeteners. The growing demand for licorice threatens wild resources and therefore a sustainable method of supplying glycyrrhizin is required. With the goal of establishing an alternative glycyrrhizin supply method not dependent on wild plants, we attempted to produce glycyrrhizin using hairy root culture. We tried to promote glycyrrhizin production by blocking competing pathways using CRISPR/Cas9-based gene editing. CYP93E3 CYP72A566 double-knockout (KO) and CYP93E3 CYP72A566 CYP716A179 LUS1 quadruple-KO variants were generated, and a substantial amount of glycyrrhizin accumulation was confirmed in both types of hairy root. Furthermore, we evaluated the potential for promoting further glycyrrhizin production by simultaneous CYP93E3 CYP72A566 double-KO and CYP88D6-overexpression. This strategy resulted in a 3-fold increase (∼1.4 mg/g) in glycyrrhizin accumulation in double-KO/CYP88D6-overexpression hairy roots, on average, compared with that of double-KO hairy roots. These findings demonstrate that the combination of blocking competing pathways and overexpression of the biosynthetic gene is important for enhancing glycyrrhizin production in G. uralensis hairy roots. Our findings provide the foundation for sustainable glycyrrhizin production using hairy root culture. Given the widespread use of genome editing technology in hairy roots, this combined with gene knockout and overexpression could be widely applied to the production of valuable substances contained in various plant roots.


Asunto(s)
Glycyrrhiza , Triterpenos , Edición Génica , Vías Biosintéticas/genética , Ácido Glicirrínico/metabolismo , Triterpenos/metabolismo , Glycyrrhiza/genética , Glycyrrhiza/metabolismo , Raíces de Plantas/genética , Raíces de Plantas/metabolismo
2.
J Fish Biol ; 93(3): 528-539, 2018 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-29938795

RESUMEN

The present study performed three experiments to establish a practical prevention strategy for the ectoparasitic flagellate Ichthyobodo salmonis and ciliate Trichodina truttae in hatchery-reared juvenile chum salmon Oncorhynchus keta using dietary supplementation with oregano essential oil. Experiment 1 showed that a diet supplemented for 3 weeks with 0.02% oregano essential oil significantly prevented infection with I. salmonis and T. truttae in juveniles reared in small tanks. Experiment 2, in outdoor hatchery ponds, demonstrated that the oregano treatment completely prevented I. salmonis infection for 52 days and T. truttae infection for 38 days. Oregano-treated juvenile mortality attributable to infection with these protozoans also decreased to 7.6% of control juvenile mortality, confirming the utility of this treatment in cultured O. keta. Physiological analyses of the oregano-treated juveniles elucidated the treatment's safety in relation to their metabolism, osmoregulation, natural immunity and olfactory responses and also detected carvacrol (a major component of oregano essential oil which shows antimicrobial activity) on the skin. In experiment 3, exposure of the two protozoans to oregano essential oil revealed a weak antiparasitic action on the body surface of the juvenile O. keta. The overall results demonstrate that dietary oregano supplementation is a practical prevention strategy for I. salmonis and T. truttae in hatchery-reared juvenile O. keta and suggest the possibility that its anti-parasitic action is attributable to a component of the oil that emerges onto the skin of the body of the fish.


Asunto(s)
Suplementos Dietéticos , Aceites Volátiles/uso terapéutico , Oncorhynchus keta/parasitología , Origanum , Enfermedades Parasitarias en Animales/prevención & control , Animales , Acuicultura , Dieta/veterinaria , Kinetoplastida , Oligohimenóforos , Fitoterapia , Piel/química
3.
J Biosci Bioeng ; 122(1): 125-30, 2016 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-26811222

RESUMEN

Quenchbody (Q-body) is an antibody fragment labeled with fluorescent dye(s), which functions as a biosensor via the antigen-dependent removal of the quenching effect on fluorophores. It is based on the principle that the fluorescence of the dye(s) attached to the antibody N-terminal region is quenched primarily by the tryptophan residues present in the variable regions, and this quenching is released when the antigen binds to the antibody, resulting in increased fluorescence intensity. Hence Q-body is utilized in various immunoassays for the rapid and sensitive detection of analytes. So far, Q-bodies have been prepared by using a cell-free translation system or by combining Escherichia coli expression and post-labeling steps. However, the above methods need antibody gene cloning, and are time-consuming. In this study, we report a novel approach to prepare Q-bodies by protein N-terminal transamination. We used the antigen-binding fragment (Fab) of an antibody against the bone-Gla-protein (BGP), a biomarker for bone diseases, which was expressed in E. coli. The purified Fab was treated with Rapoport's salt to convert the amino group at the N-terminus to a ketone group, which in turn was allowed to react with fluorescent probes that have aminooxy or hydrazide groups, to prepare a Q-body. The Q-body prepared by this method could detect the BGP-C7 antigen at concentrations as low as 10 nM. Since the approach can label the protein N-terminus directly, it could be applied for preparing Q-bodies from natural antibodies and for the rapid screening of high-performance Q-bodies.


Asunto(s)
Aminación , Anticuerpos/química , Técnicas Biosensibles/métodos , Colorantes Fluorescentes/química , Inmunoensayo/métodos , Fragmentos Fab de Inmunoglobulinas/química , Triptófano/química , Anticuerpos/inmunología , Antígenos/análisis , Antígenos/química , Antígenos/inmunología , Evaluación Preclínica de Medicamentos/métodos , Escherichia coli/genética , Escherichia coli/metabolismo , Fluorescencia , Colorantes Fluorescentes/análisis , Fragmentos Fab de Inmunoglobulinas/inmunología , Fragmentos Fab de Inmunoglobulinas/aislamiento & purificación , Cetonas/química , Osteocalcina/análisis , Osteocalcina/biosíntesis , Osteocalcina/genética , Osteocalcina/inmunología
4.
J Pharmacol Sci ; 128(4): 208-11, 2015 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-26318673

RESUMEN

Neuropathic pain is often insensitive to morphine. Our previous study has demonstrated that neuron-restrictive silencer factor represses mu opioid receptor (MOP) gene expression in the dorsal root ganglion (DRG) via histone hypoacetylation-mediated mechanisms after peripheral nerve injury, thereby causing loss of peripheral morphine analgesia. Here, we showed that histone deacetylase (HDAC) inhibitors, such as trichostatin A and valproic acid, restored peripheral and systemic morphine analgesia in neuropathic pain. Also, these agents blocked nerve injury-induced MOP down-regulation in the DRG. These results suggest that HDAC inhibitors could serve as adjuvant analgesics to morphine for the management of neuropathic pain.


Asunto(s)
Analgésicos , Regulación hacia Abajo/efectos de los fármacos , Resistencia a Medicamentos/efectos de los fármacos , Expresión Génica/efectos de los fármacos , Inhibidores de Histona Desacetilasas/farmacología , Inhibidores de Histona Desacetilasas/uso terapéutico , Morfina/farmacología , Morfina/uso terapéutico , Neuralgia/tratamiento farmacológico , Neuralgia/etiología , Traumatismos de los Nervios Periféricos/complicaciones , Receptores Opioides mu/genética , Ácido Valproico/farmacología , Ácido Valproico/uso terapéutico , Acetilación , Analgesia , Animales , Ganglios Espinales/metabolismo , Histona Desacetilasas/metabolismo , Histona Desacetilasas/fisiología , Histonas/metabolismo , Ácidos Hidroxámicos , Masculino , Ratones Endogámicos C57BL , Receptores Opioides mu/metabolismo
5.
Biosci Biotechnol Biochem ; 77(9): 1809-13, 2013.
Artículo en Inglés | MEDLINE | ID: mdl-24018671

RESUMEN

Bunching onion [Allium fistulosum L. (Liliaceae)] secretes mucus in the cavities of its green leaves. The effects of the mucus, which is consumed as food, were examined. The mucus augmented the production of tumor necrosis factor (TNF)-α and monocyte chemotactic protein (MCP)-1 from RAW 264 cells and of interleukin (IL)-12 from J774.1 cells; however, extracts from green leaves and white sheaths did not. An oral administration of this mucus to mice augmented the immune functions of peritoneal cells by increasing TNF-α and IL-12 production and phagocytosis. It also augmented interferon (IFN)-γ production from spleen cells and natural killer (NK) activity. These results suggest that an oral administration of the A. fistulosum mucus can enhance natural immunity.


Asunto(s)
Allium/química , Factores Inmunológicos/administración & dosificación , Factores Inmunológicos/farmacología , Extractos Vegetales/administración & dosificación , Extractos Vegetales/farmacología , Administración Oral , Animales , Línea Celular , Interleucina-12/biosíntesis , Macrófagos/efectos de los fármacos , Macrófagos/inmunología , Macrófagos/metabolismo , Masculino , Ratones , Ratones Endogámicos ICR , Hojas de la Planta/química , Factor de Necrosis Tumoral alfa/biosíntesis
6.
Gan To Kagaku Ryoho ; 40(7): 897-900, 2013 Jul.
Artículo en Japonés | MEDLINE | ID: mdl-23863731

RESUMEN

Cetuximab is a monoclonal antibody that binds to the EGFR, and is used in patients with colorectal cancer. The most common toxicities associated with the use of cetuximab are rash and hypomagnesemia. Hypomagnesemia is a major adverse event, but it has often been ignored in past studies and its management has not been characterized. The aim of this study was to obtain a better understanding of the overall incidence of hypomagnesemia and to evaluate the usefulness of our original treatment guidelines for hypomagnesemia in patients receiving cetuximab-based therapy. We investigated 15 patients who were treated with cetuximab(with or without combined chemotherapy)between October 2008 and November 2010. Thirteen patients developed hypomagnesemia: 11 patients had Grade 1, one patient had Grade 2, and one patient had severe hypomagnesemia(Grade 3). Grade 1 hypomagnesemia was observed after an average of 7. 5±4. 8 weeks of treatment. None of the patients developed Grade 2 or higher hypomagnesemia after the implementation of our treatment guidelines. In conclusion, cetuximab treatment is associated with a significant risk of hypomagnesemia. The early monitoring and effective management of hypomagnesemia are important for patients receiving cetuximab-based therapy.


Asunto(s)
Anticuerpos Monoclonales Humanizados/efectos adversos , Neoplasias Colorrectales/tratamiento farmacológico , Magnesio/uso terapéutico , Anciano , Anticuerpos Monoclonales Humanizados/uso terapéutico , Cetuximab , Diagnóstico Precoz , Femenino , Humanos , Magnesio/sangre , Masculino , Persona de Mediana Edad , Estudios Retrospectivos
7.
Food Chem ; 141(2): 1192-5, 2013 Nov 15.
Artículo en Inglés | MEDLINE | ID: mdl-23790903

RESUMEN

Allyl isothiocyanate, a chief component of mustard oil, exhibits anticancer effects in both cultured cancer cells and animal models. The accumulation of the N-acetylcysteine conjugate of allyl isothiocyanate, the final metabolite of allyl isothiocyanate, in urine was evaluated in rats that were orally coadministered allyl isothiocyanate with fluids (e.g., water, green tea, milk, and 10% ethanol) or corn oil. The N-acetylcysteine conjugate of allyl isothiocyanate content in urine when allyl isothiocyanate (2 or 4µmol) was coadministered with corn oil or milk showed a greater increase (1.4±0.22 or 2.7±0.34µmol or 1.2±0.32 or 2.5±0.36µmol, 1.6- to 1.8-fold or 1.5-fold, respectively) than when allyl isothiocyanate (2 or 4µmol) was coadministered with water (0.78±0.10 or 1.7±0.17µmol). This result demonstrates that corn oil and milk enhance the absorption of allyl isothiocyanate in rats.


Asunto(s)
Aceite de Maíz/metabolismo , Absorción Intestinal , Isotiocianatos/metabolismo , Leche/metabolismo , Animales , Isotiocianatos/orina , Masculino , Ratas , Ratas Wistar
8.
Bioorg Med Chem Lett ; 22(13): 4358-61, 2012 Jul 01.
Artículo en Inglés | MEDLINE | ID: mdl-22633690

RESUMEN

We report the discovery and structure-activity relationship of 2,6-disubstituted pyrazines, which are potent and selective CK2 inhibitors. Lead compound 1 was identified, and derivatives were prepared to develop potent inhibitory activity. As a result, we obtained compound 7, which was the smallest unit that retained potency. Then, introducing an aminoalkyl group at the 6-position of the indazole ring resulted in improved efficacy in both enzymatic and cell-based CK2 inhibition assays. Moreover, compound 13 showed selectivity against other kinases and in vivo efficacy in a rat nephritis model. These results show that 2,6-disubstituted pyrazines have potential as therapeutic agents for nephritis.


Asunto(s)
Quinasa de la Caseína II/antagonistas & inhibidores , Indazoles/química , Inhibidores de Proteínas Quinasas/química , Pirazinas/química , Animales , Sitios de Unión , Quinasa de la Caseína II/metabolismo , Simulación por Computador , Modelos Animales de Enfermedad , Evaluación Preclínica de Medicamentos , Humanos , Indazoles/síntesis química , Indazoles/uso terapéutico , Inyecciones Intraperitoneales , Nefritis/tratamiento farmacológico , Inhibidores de Proteínas Quinasas/síntesis química , Inhibidores de Proteínas Quinasas/uso terapéutico , Estructura Terciaria de Proteína , Pirazinas/síntesis química , Pirazinas/uso terapéutico , Ratas , Relación Estructura-Actividad
9.
Biosci Biotechnol Biochem ; 74(11): 2248-52, 2010.
Artículo en Inglés | MEDLINE | ID: mdl-21071834

RESUMEN

We investigated the ability of a ginger extract to induce an immune response in RAW 264 cells and after a repeated oral administration to mice. The squeezed ginger extract augmented the production of tumor necrosis factor-α, interleukin-6, and monocyte chemotactic protein-1 when added to RAW 264 cells. This extract was collected as its ethanol-insoluble fraction. The oral administration of the squeezed ginger extract or its ethanol-insoluble fraction once or twice to mice also augmented the tumor necrosis factor-α production in peritoneal cells; however, its long-term administration had the opposite effect. The serum corticosterone level had increased after orally administering the squeezed ginger extract and was maintained during the administration period. Oral administration of the squeezed ginger extract also inhibited arachidonic acid-induced ear edema, but its repeated administration was needed to achieve an anti-inflammatory effect. These results suggest that the repeated administration of the aqueous constituents of ginger augmented the serum corticosterone level and that this may have gradually induced anti-inflammatory activity.


Asunto(s)
Corticosterona/sangre , Extractos Vegetales/administración & dosificación , Zingiber officinale/química , Administración Oral , Animales , Antiinflamatorios/farmacología , Células Cultivadas , Macrófagos Peritoneales/metabolismo , Ratones , Extractos Vegetales/farmacología , Factor de Necrosis Tumoral alfa/biosíntesis
10.
J Neurochem ; 113(4): 1002-11, 2010 May.
Artículo en Inglés | MEDLINE | ID: mdl-20420580

RESUMEN

Lysophosphatidic acid receptor (LPA(1)) signaling initiates neuropathic pain through demyelination of the dorsal root (DR). Although LPA is found to cause down-regulation of myelin proteins underlying demyelination, the detailed mechanism remains to be determined. In the present study, we found that a single intrathecal injection of LPA evoked a dose- and time-dependent down-regulation of myelin-associated glycoprotein (MAG) in the DR through LPA(1) receptor. A similar event was also observed in ex vivo DR cultures. Interestingly, LPA-induced down-regulation of MAG was significantly inhibited by calpain inhibitors (calpain inhibitor X, E-64 and E-64d) and LPA markedly induced calpain activation in the DR. The pre-treatment with calpain inhibitors attenuated LPA-induced neuropathic pain behaviors such as hyperalgesia and allodynia. Moreover, we found that sciatic nerve injury activates calpain activity in the DR in a LPA(1) receptor-dependent manner. The E-64d treatments significantly blocked nerve injury-induced MAG down-regulation and neuropathic pain. However, there was no significant calpain activation in the DR by complete Freund's adjuvant treatment, and E-64d failed to show anti-hyperalgesic effects in this inflammation model. The present study provides strong evidence that LPA-induced calpain activation plays a crucial role in the manifestation of neuropathic pain through MAG down-regulation in the DR.


Asunto(s)
Calpaína/metabolismo , Enfermedades Desmielinizantes/metabolismo , Glicoproteína Asociada a Mielina/metabolismo , Enfermedades del Sistema Nervioso Periférico/metabolismo , Células Receptoras Sensoriales/metabolismo , Raíces Nerviosas Espinales/metabolismo , Animales , Inhibidores de Cisteína Proteinasa/farmacología , Enfermedades Desmielinizantes/etiología , Enfermedades Desmielinizantes/fisiopatología , Modelos Animales de Enfermedad , Activación Enzimática/efectos de los fármacos , Activación Enzimática/fisiología , Leucina/análogos & derivados , Leucina/farmacología , Lisofosfolípidos/toxicidad , Masculino , Ratones , Ratones Endogámicos C57BL , Ratones Noqueados , Neurotoxinas/toxicidad , Enfermedades del Sistema Nervioso Periférico/fisiopatología , Receptores del Ácido Lisofosfatídico/efectos de los fármacos , Receptores del Ácido Lisofosfatídico/metabolismo , Neuropatía Ciática/metabolismo , Neuropatía Ciática/fisiopatología , Células Receptoras Sensoriales/patología , Raíces Nerviosas Espinales/patología
11.
Biochem Biophys Res Commun ; 381(1): 54-8, 2009 Mar 27.
Artículo en Inglés | MEDLINE | ID: mdl-19351594

RESUMEN

One of the great challenges of oncology is to improve methods for early tumor detection. Thus tumor cell-targeted optical imaging has been intensively studied. Bioimaging with upconversion (UC) phosphors (UCPs) is of considerable interest due to a variety of possible applications taking advantage of infrared-to-visible luminescence. Here we report for the first time tumor cell-targeted UC imaging using UCPs modified with cyclic RGD peptide (RGD-Y2O3). Cyclic RGD peptide binds specifically to integrin alphavbeta3 which is highly expressed in a tumor cell surface of certain cancer types but not in normal tissues. Since UC emission from RGD-Y2O3 was observed for U87MG cancer cell (high integrin alphavbeta3 expression), but not for MCF-7 cancer cell (low integrin alphavbeta3 expression), this UC imaging is considered to be integrin alphavbeta3 specific. The non-invasive imaging of integrin alphavbeta3 expression using UCP-based probes will have great potential in cancer imaging in general in living subjects.


Asunto(s)
Nanopartículas/química , Neoplasias/diagnóstico , Péptidos Cíclicos/química , Fósforo/química , Línea Celular Tumoral , Humanos , Rayos Infrarrojos , Microscopía/métodos , Neoplasias/metabolismo , Péptidos Cíclicos/metabolismo , Coloración y Etiquetado
12.
J Theor Biol ; 253(1): 55-60, 2008 Jul 07.
Artículo en Inglés | MEDLINE | ID: mdl-18179802

RESUMEN

We consider a rumor transmission model with various contact interactions and explore what effect such interactions have on the spread of a rumor, in particular whether they can explain the rumor recursion. Through mathematical analysis and computer simulations, we conjecture that rumor recursion remains a major challenge to mathematical models of rumors beyond our model proposed here.


Asunto(s)
Simulación por Computador , Modelos Psicológicos , Comunicación Persuasiva , Conducta Social , Humanos , Sugestión
13.
Cell Mol Neurobiol ; 26(3): 237-46, 2006 May.
Artículo en Inglés | MEDLINE | ID: mdl-16767511

RESUMEN

1. The Ca(2+)-mediated regulation of interaction between FGF-1 and S100A13 in NG108-15 cells was studied. When the stress by depriving B27 supplement from the culture was given, cellular levels of both proteins were decreased, while their releases were significantly increased within 3 h. These stress-induced changes were all abolished by amlexanox, an anti-allergic drug. 2. These releases were significantly inhibited by the addition of EGTA or BAPTA-AM, cellular or extracellular Ca(2+)-chelating agent, respectively. The addition of omega-conotoxin GVIA, a N-type Ca(2+)-channel blocker caused a complete inhibition of the release, while increased the cytosolic levels of both proteins. However, omega-conotoxin MVIIC, the non-N-type Ca(2+)-channel blocker was ineffective. 3. In NG108-15 cells, which had been transfected with Venus-FGF-1 and CFP-S100A13, the supplement-deprivation stress caused several spike-type fluorescence resonance energy transfer (FRET) signals, suggesting that both proteins showing interaction would be immediately released. These spikes were completely abolished by the addition of omega-conotoxin GVIA. However, the addition of amlexanox caused bell-shaped FRET signals without spikes. 4. Thus, it is suggested that the interaction between FGF-1 and S100A13 responsible for stress-induced non-vesicular release is dependent of Ca(2+)-influx through N-type Ca(2+)-channels.


Asunto(s)
Canales de Calcio Tipo N/metabolismo , Exocitosis/fisiología , Factor 1 de Crecimiento de Fibroblastos/metabolismo , Proteínas S100/metabolismo , Vesículas Secretoras/metabolismo , Aminopiridinas/metabolismo , Animales , Antialérgicos/metabolismo , Calcio/metabolismo , Bloqueadores de los Canales de Calcio/metabolismo , Línea Celular , Quelantes/metabolismo , Ácido Egtácico/análogos & derivados , Ácido Egtácico/metabolismo , Factor 1 de Crecimiento de Fibroblastos/genética , Transferencia Resonante de Energía de Fluorescencia , Proteínas Luminiscentes/genética , Proteínas Luminiscentes/metabolismo , Estrés Oxidativo , Ratas , Proteínas S100/genética , omega-Conotoxina GVIA/metabolismo
14.
Mol Pain ; 2: 16, 2006 May 08.
Artículo en Inglés | MEDLINE | ID: mdl-16681855

RESUMEN

In the present study, we first report an in vivo characterization of flexor responses induced by three distinct sine-wave stimuli in the electrical stimulation-induced paw flexion (EPF) test in mice. The fixed sine-wave electric stimulations of 5 Hz (C-fiber), 250 Hz (Adelta-fiber) and 2000 Hz (Abeta-fiber) to the hind paw of mice induced a paw-flexion response and vocalization. The average threshold for paw flexor responses by sine-wave stimulations was much lower than that for vocalization. Neonatally (P3) pretreatment with capsaicin to degenerate polymodal substance P-ergic C-fiber neurons increased the threshold to 5 Hz (C-fiber) stimuli, but not to 250 Hz (Adelta-fiber) and 2000 Hz (Abeta-fiber). The flexor responses to 5 Hz stimuli were significantly blocked by intrathecal (i.t.) pretreatment with both CP-99994 and MK-801, an NK1 and NMDA receptor antagonist, respectively, but not by CNQX, an AMPA/kainate receptor antagonist. On the other hand, the flexor responses induced by 250 Hz stimuli were blocked by MK-801 (i.t.) but not by CP-99994 or CNQX. In contrast, flexor responses induced by 2000 Hz stimuli were only blocked by CNQX treatment. These data suggest that we have identified three pharmacologically different categories of responses mediated through different primary afferent fibers. Furthermore, we also carried out characterization of the in vivo functional sensitivity of each of the sensory fiber types in nerve-injured mice using the EPF test, and found that the threshold to both 250 Hz and 2000 Hz stimulations were markedly decreased, whereas the threshold to 5 Hz stimulations was significantly increased. Thus we found opposing effects on specific sensory fiber-mediated responses as a result of nerve injury in mice. These results also suggest that the EPF analysis is useful for the evaluation of plasticity in sensory functions in animal disease models.


Asunto(s)
Neuronas Aferentes/fisiología , Nociceptores/fisiopatología , Umbral del Dolor/fisiología , Dolor/fisiopatología , Nervios Periféricos/fisiopatología , Raíces Nerviosas Espinales/fisiopatología , Animales , Animales Recién Nacidos , Capsaicina/efectos adversos , Modelos Animales de Enfermedad , Estimulación Eléctrica/efectos adversos , Estimulación Eléctrica/métodos , Pie/inervación , Pie/fisiopatología , Miembro Posterior/inervación , Miembro Posterior/fisiopatología , Masculino , Ratones , Fibras Nerviosas Amielínicas/efectos de los fármacos , Fibras Nerviosas Amielínicas/metabolismo , Antagonistas del Receptor de Neuroquinina-1 , Plasticidad Neuronal/efectos de los fármacos , Plasticidad Neuronal/fisiología , Neuronas Aferentes/clasificación , Neuronas Aferentes/efectos de los fármacos , Nociceptores/efectos de los fármacos , Nociceptores/lesiones , Dolor/inducido químicamente , Dimensión del Dolor/métodos , Umbral del Dolor/efectos de los fármacos , Traumatismos de los Nervios Periféricos , Nervios Periféricos/efectos de los fármacos , Valor Predictivo de las Pruebas , Receptores de N-Metil-D-Aspartato/antagonistas & inhibidores , Receptores de N-Metil-D-Aspartato/metabolismo , Receptores de Neuroquinina-1/metabolismo , Reflejo/efectos de los fármacos , Reflejo/fisiología , Raíces Nerviosas Espinales/efectos de los fármacos , Raíces Nerviosas Espinales/lesiones , Sustancia P/metabolismo , Transmisión Sináptica/efectos de los fármacos , Transmisión Sináptica/fisiología
15.
Physiol Behav ; 82(2-3): 199-203, 2004 Sep 15.
Artículo en Inglés | MEDLINE | ID: mdl-15276781

RESUMEN

The effect of chicken motilin on food intake was investigated in meat-type chicks under ad libitum feeding, refeeding, and fasting conditions. We found that the intracerebroventricular injection of chicken motilin (0.1 and 0.2 microg) tended to increase food intake under ad libitum feeding and refeeding conditions at 60 min postinjection, but the differences were not significant (P>.05). On the other hand, central administration of chicken motilin (0.2 and 0.4 microg) showed a tendency to suppress feeding of fasted chicks as well as the result of high dose (5.0 microg) under ad libitum feeding conditions. Therefore, the results presented here suggest that central motilin alone does not induce hyperphagia in meat-type chicks.


Asunto(s)
Regulación del Apetito/fisiología , Ayuno/fisiología , Conducta Alimentaria/fisiología , Hiperfagia/fisiopatología , Motilina/fisiología , Animales , Regulación del Apetito/efectos de los fármacos , Pollos , Relación Dosis-Respuesta a Droga , Ingestión de Alimentos/efectos de los fármacos , Ingestión de Alimentos/fisiología , Conducta Alimentaria/efectos de los fármacos , Hiperfagia/inducido químicamente , Inyecciones Intraventriculares , Masculino , Motilina/administración & dosificación
16.
Int J Oncol ; 23(1): 49-59, 2003 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-12792775

RESUMEN

The clinical outcome of patients with colorectal cancer frequently varies even if they are at the same clinicopathologic stage. Alternative superior tumor markers of colorectal cancer are needed for prediction of clinical outcome. To clarify the regulatory factors in colorectal cancers, we examined differential expression profiles using cDNA macroarray technique with surgically resected specimens obtained from the patients with colorectal cancer. The gene profiles by an average-linkage hierarchical clustering analysis were found to be almost separable into two groups: tumor group and normal mucosa group. The relationship between several clinicopathologic factors and cancer related genes were investigated by using statistical analyses including principal component analysis (PCA). c-myc-binding protein MM-1, and c-jun proto-oncogene were identified as possible markers of tumor histology and clinical prognosis and early growth response protein 1 (EGR1) was selected to play an important role in progression of clinical stage. We conclude that, with PCA method, we successfully selected the genes relevant to clinicopathologic factors using limited population of clinical samples.


Asunto(s)
Neoplasias Colorrectales/genética , Regulación Neoplásica de la Expresión Génica , Proteínas Inmediatas-Precoces , Análisis de Secuencia por Matrices de Oligonucleótidos/métodos , Anciano , Anciano de 80 o más Años , Análisis por Conglomerados , ADN Complementario/metabolismo , Proteínas de Unión al ADN/metabolismo , Regulación hacia Abajo , Proteína 1 de la Respuesta de Crecimiento Precoz , Femenino , Humanos , Masculino , Persona de Mediana Edad , Hibridación de Ácido Nucleico , Análisis de Componente Principal , Pronóstico , Proto-Oncogenes Mas , Proteínas Proto-Oncogénicas c-jun/metabolismo , Proteínas Represoras/metabolismo , Factores de Transcripción/metabolismo , Regulación hacia Arriba
17.
J Pharmacol Exp Ther ; 306(2): 709-17, 2003 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-12724350

RESUMEN

Topical capsaicin is believed to alleviate pain by desensitizing the vanilloid receptor 1 (VR1) at the peripheral nerve endings. Here, we report that an up-regulation of VR1 expression on myelinated fibers contributes to the antihyperalgesic effect of capsaicin cream in streptozotocin (STZ)-induced diabetic neuropathic pain. Intravenous injection of STZ (200 mg/kg) in mice caused rapid onset of diabetes within 24 h. Thermal and mechanical hyperalgesia developed by 3 days after STZ injection and persisted at all time points tested until 28 days. There was also hyperalgesic response to intraplantar (i.pl.) prostaglandin I2 (PGI2) agonist-induced nociception in such mice. Application of capsaicin cream dose dependently reversed the thermal, mechanical, and PGI2 agonist-induced hyperalgesia observed in the diabetic mice. The i.pl. injection of capsaicin solution (0.4 microg/20 microl) produced nociceptive biting-licking responses in control mice, and these responses were significantly increased in STZ-induced diabetic mice. After neonatal capsaicin-treatment, which destroys most unmyelinated C-fibers, the i.pl. capsaicin-induced biting-licking responses were almost abolished. However, in neonatal capsaicin-treated diabetic mice, the i.pl. capsaicin-induced biting-licking responses reappeared. The i.pl. capsaicin-induced biting-licking responses were blocked by the competitive VR1 antagonist capsazepine. All these results suggest an increase in capsaicin receptor on myelinated fibers due to diabetes. Finally, we confirmed the up-regulation of VR1 expression on myelinated primary afferent neurons of diabetic mice by immunohistochemistry. Together, our results suggest that increased expression of VR1 on myelinated fibers might contribute to the antihyperalgesic effect of topical capsaicin in diabetic neuropathic pain.


Asunto(s)
Capsaicina/uso terapéutico , Neuropatías Diabéticas/complicaciones , Hiperalgesia/tratamiento farmacológico , Neuronas Aferentes/metabolismo , Dolor/tratamiento farmacológico , Receptores de Droga/metabolismo , Vías Aferentes/metabolismo , Animales , Neuropatías Diabéticas/inducido químicamente , Modelos Animales de Enfermedad , Calor , Hiperalgesia/etiología , Inyecciones Intravenosas , Ratones , Fibras Nerviosas Mielínicas , Neuronas Aferentes/efectos de los fármacos , Dolor/etiología , Fenotipo , Estreptozocina
18.
Biol Pharm Bull ; 26(4): 560-3, 2003 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-12673045

RESUMEN

In the present study, the effects of perilla leaf extract (PLE) and luteolin on 7,12-dimethylbenz[a]anthracene (DMBA)- and 12-O-tetradecanoylphorbol-13-acetate (TPA)-induced skin papillomas in mice were investigated. Topical application of PLE prior to TPA treatment in DMBA-initiated mouse skin resulted in a significant reduction in tumor incidence and multiplicity. An even more potent preventive effect was observed with topical application of luteolin, which we previously identified as an antiinflammatory constituent. PLE was dissolved in drinking water at a 0.05% dose and mice ingested it ad libitum; no significant difference was observed in tumor incidence or multiplicity but there was a significant reduction in tumor volume between the PLE-treated and untreated groups. These results suggest that PLE has potent antipromotion activity and ingesting it as a daily food may provide a beneficial chemopreventive effect.


Asunto(s)
Transformación Celular Neoplásica/efectos de los fármacos , Flavonoides/uso terapéutico , Perilla frutescens , Neoplasias Cutáneas/prevención & control , Animales , Transformación Celular Neoplásica/patología , Femenino , Flavonoides/aislamiento & purificación , Inhibidores de Crecimiento/aislamiento & purificación , Inhibidores de Crecimiento/uso terapéutico , Luteolina , Ratones , Ratones Endogámicos ICR , Extractos Vegetales/aislamiento & purificación , Extractos Vegetales/uso terapéutico , Hojas de la Planta , Neoplasias Cutáneas/inducido químicamente , Neoplasias Cutáneas/tratamiento farmacológico
19.
Trends Endocrinol Metab ; 14(1): 14-9, 2003 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-12475607

RESUMEN

Tuberoinfundibular peptide of 39 residues (TIP39), a neuropeptide recently purified from the hypothalamus, appears to be an endogenous ligand for the parathyroid hormone 2 (PTH2) receptor. PTH2 receptors are present in several central nervous system and peripheral areas and are particularly concentrated in the hypothalamus, limbic areas and the outer layers of the spinal cord dorsal horn. TIP39-containing neuronal cell bodies have been identified in the subparafascicular area and the medial paralemniscal nucleus, two brainstem regions that project widely through the entire neuraxis. Treatment of hypothalamic explants with TIP39, and intraventricular injection of the peptide, suggest that it might stimulate hypothalamic-releasing factor secretion. Injection of TIP39, and sequestration of endogenous TIP39 by intrathecal injection of an antibody to TIP39, have provided evidence that it is involved in some aspects of pain sensitivity. Thus, TIP39 might be a new neuromodulator.


Asunto(s)
Encéfalo/metabolismo , Neuropéptidos/metabolismo , Neurotransmisores/metabolismo , Receptores de Hormona Paratiroidea/metabolismo , Secuencia de Aminoácidos , Animales , Tronco Encefálico/metabolismo , Humanos , Hipotálamo/metabolismo , Sistema Límbico/metabolismo , Datos de Secuencia Molecular , Dolor/metabolismo , Hormonas Liberadoras de Hormona Hipofisaria/metabolismo , Células del Asta Posterior/metabolismo , Receptor de Hormona Paratiroídea Tipo 2 , Médula Espinal/metabolismo
20.
Biol Pharm Bull ; 25(9): 1197-202, 2002 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-12230117

RESUMEN

Oral administration of the perilla leaf extract (PLE) to mice inhibits inflammation, allergic response, and tumor necrosis factor-alpha production. We also found that PLE suppressed the tumor necrosis factor-alpha (TNF-alpha) production in vitro. Using the inhibitory activity of TNF-alpha production in vitro as the index for isolation, we searched the active constituents from PLE and isolated luteolin, rosmarinic acid and caffeic acid as active components. Among the isolated compounds, only luteolin showed in vivo activity: inhibition of serum tumor necrosis factor-alpha production, inhibition of arachidonic acid-induced ear edema, inhibition of 12-O-tetradecanoylphorbol-13-acetate-induced ear edema and inhibition of oxazolone-induced allergic edema. These results suggest that luteolin is a genuinely active constituent which is accountable for the oral effects of perilla.


Asunto(s)
Antialérgicos/uso terapéutico , Antiinflamatorios no Esteroideos/uso terapéutico , Medicamentos Herbarios Chinos/uso terapéutico , Flavonoides/uso terapéutico , Perilla frutescens , Animales , Antialérgicos/aislamiento & purificación , Antialérgicos/farmacología , Antiinflamatorios no Esteroideos/aislamiento & purificación , Antiinflamatorios no Esteroideos/farmacología , Relación Dosis-Respuesta a Droga , Medicamentos Herbarios Chinos/aislamiento & purificación , Medicamentos Herbarios Chinos/farmacología , Edema/tratamiento farmacológico , Flavonoides/aislamiento & purificación , Flavonoides/farmacología , Luteolina , Masculino , Ratones , Ratones Endogámicos ICR , Fitoterapia/métodos , Hojas de la Planta , Factor de Necrosis Tumoral alfa/antagonistas & inhibidores , Factor de Necrosis Tumoral alfa/metabolismo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA